StonvexLoading…
StonvexStonvexStonvexCore line items from GNLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $448.00K | $4.36M | $2.99M | $2.26M |
Operating Income | $-5.57M | $-54.25M | $-15.66M | $-6.73M |
Net Income | $-18.36M | $-85.58M | $-16.02M | $-7.08M |
EPS (Diluted) | $-4.49 | $-11.42 | $-19.88 | $-13.92 |
Total Assets | $56.22M | $74.93M | $17.64M | $31.78M |
Total Liabilities | $6.14M | $7.21M | $6.63M | $11.83M |
Cash & Equivalents | $13.32M | $32.51M | $1.81M | $5.72M |
Free Cash Flow OCF − CapEx | Not available | $-16.36M | $-11.88M | $-7.96M |
Shares Outstanding | 4.09M | 7.49M | 805.48K | 508.49K |